Follow
Ruud Verstegen
Ruud Verstegen
The Hospital for Sick Children, University of Toronto
Verified email at sickkids.ca
Title
Cited by
Cited by
Year
Intrinsic defect of the immune system in children with Down syndrome: a review
MAA Kusters, RHJ Verstegen, EFA Gemen, E De Vries
Clinical & Experimental Immunology 156 (2), 189-193, 2009
3202009
Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help
RHJ Verstegen, MAA Kusters, EFA Gemen, E De Vries
Pediatric Research 67 (5), 563-569, 2010
1142010
Both normal memory counts and decreased naive cells favor intrinsic defect over early senescence of Down syndrome T lymphocytes
MAA Kusters, EFA Gemen, RHJ Verstegen, PC Wever, E de Vries
Pediatric research 67 (5), 557-562, 2010
672010
Defective B-cell memory in patients with Down syndrome
RHJ Verstegen, GJ Driessen, SJW Bartol, CJM Van Noesel, L Boon, ...
Journal of allergy and clinical immunology 134 (6), 1346-1353. e9, 2014
632014
Pediatric cannabis intoxication trends in the pre and post-legalization era
N Cohen, L Galvis Blanco, A Davis, A Kahane, M Mathew, S Schuh, ...
Clinical Toxicology 60 (1), 53-58, 2022
492022
Inborn errors of adaptive immunity in Down syndrome
RHJ Verstegen, MAA Kusters
Journal of Clinical Immunology 40 (6), 791-806, 2020
442020
Clinical implications of immune‐mediated diseases in children with Down syndrome
RHJ Verstegen, KJJ Chang, MAA Kusters
Pediatric allergy and immunology 31 (2), 117-123, 2020
442020
Drugs in lactation
RHJ Verstegen, S Ito
Journal of Obstetrics and Gynaecology Research 45 (3), 522-531, 2019
432019
Infant drug exposure via breast milk
RHJ Verstegen, PO Anderson, S Ito
British Journal of Clinical Pharmacology 88 (10), 4311-4327, 2022
422022
Down syndrome: is it really characterized by precocious immunosenescence?
MAA Kusters, RHJ Verstegen, E De Vries
Aging and disease 2 (6), 538, 2011
422011
Significant impact of recurrent respiratory tract infections in children with D own syndrome
RHJ Verstegen, HBM van Gameren‐Oosterom, M Fekkes, E Dusseldorp, ...
Child: care, health and development 39 (6), 801-809, 2013
352013
Assessment of the implementation of pharmacogenomic testing in a pediatric tertiary care setting
I Cohn, R Manshaei, E Liston, JBA Okello, R Khan, MR Curtis, AJ Krupski, ...
JAMA network open 4 (5), e2110446-e2110446, 2021
322021
Autoinflammation due to homozygous S208 MEFV mutation
Y Hong, ASI Standing, S Nanthapisal, N Sebire, S Jolles, E Omoyinmi, ...
Annals of the rheumatic diseases 78 (4), 571-573, 2019
322019
Impact of Down syndrome on the performance of neonatal screening assays for severe primary immunodeficiency diseases
RH Verstegen, S Borte, LA Bok, PH Van Zwieten, U von Döbeln, ...
J Allergy Clin Immunol 133 (4), 1208-1211, 2014
322014
Towards therapeutic drug monitoring of TNF inhibitors for children with juvenile idiopathic arthritis: a scoping review
RHJ Verstegen, R McMillan, BM Feldman, S Ito, RM Laxer
Rheumatology 59 (2), 386-397, 2020
242020
Epidemiology of respiratory symptoms in children with Down syndrome: a nationwide prospective web-based parent-reported study
RHJ Verstegen, RWNM van Hout, E de Vries
BMC pediatrics 14, 1-5, 2014
222014
The future of precision medicine
RHJ Verstegen, S Ito
Clinical Pharmacology & Therapeutics 106 (5), 903-906, 2019
212019
Repair of surgically created diaphragmatic defect in rat with use of a crosslinked porous collagen scaffold
KM Brouwer, WF Daamen, D Reijnen, RH Verstegen, G Lammers, ...
Journal of Tissue Engineering and Regenerative Medicine 7 (7), 552-561, 2013
212013
Increased circulating apoptotic lymphocytes in children with Down syndrome
EFA Gemen, RHJ Verstegen, J Leuvenink, E de Vries
Pediatric Blood & Cancer 59 (7), 1310-1312, 2012
202012
Lymphatic edema in congenital disorders of glycosylation
RHJ Verstegen, M Theodore, H van de Klerk, E Morava
JIMD Reports-Case and Research Reports, 2012/1, 113-116, 2012
162012
The system can't perform the operation now. Try again later.
Articles 1–20